© 2001 American Heart Association, Inc.
Molecular Medicine |
ELF-1 Is a Transcriptional Regulator of the Tie2 Gene During Vascular Development
From the Cardiology Division (A.D., J.G., S.R., P.O.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass; New England Baptist Bone and Joint Institute (A.D., J.G., S.R., T.A.L., P.O.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass; and Department of Molecular Cell and Developmental Biology (S.T., L.I.-A.), University of California at Los Angeles, Los Angeles, Calif.
Correspondence to Peter Oettgen, Harvard Institutes of Medicine, 4 Blackfan Circle, Boston, MA 02115. E-mail joettgen{at}caregroup.harvard.edu
Abstract—Vascular development requires the tightly coordinated expression of several growth factors and their receptors. Among these are the Tie1 and Tie2 receptors, which are almost exclusively endothelial cell–specific. The critical transcriptional regulators of vascular-specific gene expression remain largely unknown. The Ets factors are a family of evolutionarily conserved transcription factors that regulate genes involved in cellular growth and differentiation. We have recently shown that the Ets factor NERF is a strong transactivator of the Tie1 and Tie2 genes. To extend these studies, we have begun to identify the Ets factors that are expressed in developing blood vessels of the chicken chorioallantoic membrane (CAM), a highly vascular embryonic network. RNA was extracted from microdissected CAM blood vessels, and reverse transcriptase–polymerase chain reaction was performed using oligonucleotides encoding conserved amino acids within the Ets domain. One of the polymerase chain reaction fragments was subcloned and identified as the chicken homologue of the Ets factor ELF-1, cELF-1. ELF-1 is most closely related to the Ets factor NERF. In situ hybridization and immunohistochemistry demonstrate that cELF-1 is enriched in developing chicken blood vessels. cELF-1 is also a strong transactivator of the Tie1 and Tie2 genes and can bind to conserved Ets sites within the promoters of these genes. A complex of similar size forms when gel shifts are performed with cellular extracts derived from the CAM blood vessels, which is recognized by an antibody against cELF-1. In summary, ELF-1 belongs to a subset of Ets factors that regulate vascular-specific gene expression during blood vessel development.
Key Words: vascular development • angiogenesis • Tie2 gene • gene expression
This article has been cited by other articles:
 |
|
 |
|
  L. Yuan, V. Nikolova-Krstevski, Y. Zhan, M. Kondo, M. Bhasin, L. Varghese, K. Yano, C. V. Carman, W. C. Aird, and P. Oettgen Antiinflammatory Effects of the ETS Factor ERG in Endothelial Cells Are Mediated Through Transcriptional Repression of the Interleukin-8 Gene Circ. Res., May 8, 2009; 104(9): 1049 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Okada, E. Jin, V. Nikolova-Krstevski, K. Yano, J. Liu, D. Beeler, K. Spokes, M. Kitayama, N. Funahashi, T. Doi, et al. A GABP-binding element in the Robo4 promoter is necessary for endothelial expression in vivo Blood, September 15, 2008; 112(6): 2336 - 2339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Teichert, J. A. Scott, G. B. Robb, Y.-Q. Zhou, S.-N. Zhu, M. Lem, A. Keightley, B. M. Steer, A. C. Schuh, S. L. Adamson, et al. Endothelial Nitric Oxide Synthase Gene Expression During Murine Embryogenesis: Commencement of Expression in the Embryo Occurs With the Establishment of a Unidirectional Circulatory System Circ. Res., July 3, 2008; 103(1): 24 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Okada, K. Yano, E. Jin, N. Funahashi, M. Kitayama, T. Doi, K. Spokes, D. L. Beeler, S.-C. Shih, H. Okada, et al. A Three-Kilobase Fragment of the Human Robo4 Promoter Directs Cell Type-Specific Expression in Endothelium Circ. Res., June 22, 2007; 100(12): 1712 - 1722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Oettgen Regulation of Vascular Inflammation and Remodeling by ETS Factors Circ. Res., November 24, 2006; 99(11): 1159 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hamik, B. Wang, and M. K. Jain Transcriptional Regulators of Angiogenesis Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 1936 - 1947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Pimanda, W.Y. I. Chan, I. J. Donaldson, M. Bowen, A. R. Green, and B. Gottgens Endoglin expression in the endothelium is regulated by Fli-1, Erg, and Elf-1 acting on the promoter and a -8-kb enhancer Blood, June 15, 2006; 107(12): 4737 - 4745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Huang, C. Brown, W. Ni, E. Maynard, A. C. Rigby, and P. Oettgen Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis Blood, April 15, 2006; 107(8): 3153 - 3160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-R. Landry, S. Kinston, K. Knezevic, I. J. Donaldson, A. R. Green, and B. Gottgens Fli1, Elf1, and Ets1 regulate the proximal promoter of the LMO2 gene in endothelial cells Blood, October 15, 2005; 106(8): 2680 - 2687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hegen, S. Koidl, K. Weindel, D. Marme, H. G. Augustin, and U. Fiedler Expression of Angiopoietin-2 in Endothelial Cells Is Controlled by Positive and Negative Regulatory Promoter Elements Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1803 - 1809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, R. Fang, J.-Y. Cho, T. A. Libermann, and P. Oettgen Positive and Negative Modulation of the Transcriptional Activity of the ETS Factor ESE-1 through Interaction with p300, CREB-binding Protein, and Ku 70/86 J. Biol. Chem., June 11, 2004; 279(24): 25241 - 25250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Morikawa and P. Cserjesi Extra-embryonic vasculature development is regulated by the transcription factor HAND1 Development, May 1, 2004; 131(9): 2195 - 2204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Seki, K.-H. Hong, J. Yun, S.-J. Kim, and S. P. Oh Isolation of a Regulatory Region of Activin Receptor-Like Kinase 1 Gene Sufficient for Arterial Endothelium-Specific Expression Circ. Res., April 30, 2004; 94(8): e72 - e77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Gottgens, C. Broccardo, M.-J. Sanchez, S. Deveaux, G. Murphy, J. R. Gothert, E. Kotsopoulou, S. Kinston, L. Delaney, S. Piltz, et al. The scl +18/19 Stem Cell Enhancer Is Not Required for Hematopoiesis: Identification of a 5' Bifunctional Hematopoietic-Endothelial Enhancer Bound by Fli-1 and Elf-1 Mol. Cell. Biol., March 1, 2004; 24(5): 1870 - 1883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gaspar, S. Thai, C. Voland, A. Dube, T. A. Libermann, M.L. Iruela-Arispe, and P. Oettgen Opposing Functions of the Ets Factors NERF and ELF-1 During Chicken Blood Vessel Development Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1106 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Oettgen Transcriptional Regulation of Vascular Development Circ. Res., August 31, 2001; 89(5): 380 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. N. Sato Transcriptional Regulation of Vascular Development Circ. Res., February 2, 2001; 88(2): 127 - 128. [Full Text] [PDF]
|
|